The role of immunotherapy in the management of patients with renal cell carcinoma and brain metastases
- PMID: 32016032
- PMCID: PMC6976477
- DOI: 10.21037/atm.2019.10.31
The role of immunotherapy in the management of patients with renal cell carcinoma and brain metastases
Conflict of interest statement
Conflicts of Interest: MS Ahluwalia: Receipt of grants/research supports: Astrazeneca, Abbvie, BMS, Bayer, Incyte, Pharmacyclics, Novocure, Merck; Receipt of honoraria or consultation fees: Elsevier, Wiley, Astrazeneca, Abvvie, VBI Vaccines, Flatiron, Varian Medical Systems, Prime Education, Bayer, karyopharm, Tocagen, Forma therapeutics; Stock shareholder: Doctible, Mimivax. The other author has no conflicts of interest to declare.
Comment on
-
Safety and Efficacy of Nivolumab in Brain Metastases From Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study.J Clin Oncol. 2019 Aug 10;37(23):2008-2016. doi: 10.1200/JCO.18.02218. Epub 2019 Jun 13. J Clin Oncol. 2019. PMID: 31194611 Clinical Trial.
Similar articles
-
Management of Brain Metastases in the New Era of Checkpoint Inhibition.Curr Neurol Neurosci Rep. 2018 Aug 18;18(10):70. doi: 10.1007/s11910-018-0877-8. Curr Neurol Neurosci Rep. 2018. PMID: 30121715 Review.
-
The Agnostic Role of Site of Metastasis in Predicting Outcomes in Cancer Patients Treated with Immunotherapy.Vaccines (Basel). 2020 Apr 28;8(2):203. doi: 10.3390/vaccines8020203. Vaccines (Basel). 2020. PMID: 32353934 Free PMC article.
-
[Usefulness and limitation of immunotherapy of metastatic renal cell carcinoma with autologous lymphokine-activated killer cells and interleukin 2].Nihon Hinyokika Gakkai Zasshi. 1991 Mar;82(3):395-404. doi: 10.5980/jpnjurol1989.82.395. Nihon Hinyokika Gakkai Zasshi. 1991. PMID: 2072602 Japanese.
-
Outcome predictors of gamma knife radiosurgery for renal cell carcinoma metastases.Neurosurgery. 2011 Dec;69(6):1232-9. doi: 10.1227/NEU.0b013e31822b2fdc. Neurosurgery. 2011. PMID: 21716155
-
Emerging Trends in the Management of Brain Metastases from Non-small Cell Lung Cancer.Curr Oncol Rep. 2018 May 7;20(7):54. doi: 10.1007/s11912-018-0695-9. Curr Oncol Rep. 2018. PMID: 29736685 Review.
Cited by
-
The Complete Response of a Renal Cell Carcinoma Metastatic to Brain, Lungs, and Liver to Second-Line Nivolumab: A Case Report.Cureus. 2022 Sep 28;14(9):e29680. doi: 10.7759/cureus.29680. eCollection 2022 Sep. Cureus. 2022. PMID: 36321052 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources